SCOPUS 정보 검색 플랫폼

Chemistry of Heterocyclic Compounds

Volumn 48, Issue 1, 2012, Pages 27-32

Bioisosteric equivalence of five-membered heterocycles

(1) Dudkin, V Y a

a MERCK RESEARCH LABORATORIES (United States)

Author keywords

bioisosterism; heterocycles; lead optimization; medicinal chemistry; scaffold hopping.

Indexed keywords

EID: 84861231411 PISSN: 00093122 EISSN: 15738353 Source Type: Journal
DOI: 10.1007/s10593-012-0964-8 Document Type: Article

Times cited : (11)

References (18)

1
- 0004169648
- Academic Press London
- C. G. Wermuth, The Practice of Medicinal Chemistry, Academic Press, London, 1996.
- (1996) The Practice of Medicinal Chemistry
- Wermuth, C.G.¹

2
- 7744243992
- 10.1021/cr950066q 1:CAS:528:DyaK28XntFSitLg%3D
- GA Patani EJ LaVoie 1996 Chem. Rev. 96 3147 10.1021/cr950066q 1:CAS:528:DyaK28XntFSitLg%3D
- (1996) Chem. Rev. , vol.96 , pp. 3147
- Patani, G.A.¹ Lavoie, E.J.²

3
- 84861233850
- Washington
- H. L. Friedman, NAS-NRS Publication No. 206, Washington (1951), p. 295.
- (1951) NAS-NRS Publication No. 206 , pp. 295
- Friedman, H.L.¹

4
- 77949484597
- 10.1016/j.ejmech.2010.01.025 1:CAS:528:DC%2BC3cXjs12qs7s%3D
- CF Matta AA Arabi DF Weaver 2010 Eur. J. Med. Chem 45 1868 10.1016/j.ejmech.2010.01.025 1:CAS:528:DC%2BC3cXjs12qs7s%3D
- (2010) Eur. J. Med. Chem , vol.45 , pp. 1868
- Matta, C.F.¹ Arabi, A.A.² Weaver, D.F.³

5
- 77952732009
- 10.1002/minf.201000019 1:CAS:528:DC%2BC3cXmsVSgur4%3D
- SR Langdon P Ertl N Brown 2010 Mol. Inf. 29 366 10.1002/minf.201000019 1:CAS:528:DC%2BC3cXmsVSgur4%3D
- (2010) Mol. Inf. , vol.29 , pp. 366
- Langdon, S.R.¹ Ertl, P.² Brown, N.³

6
- 79955419410
- 10.1021/jm1013693 1:CAS:528:DC%2BC3MXjsVCnu7o%3D
- NA Meanwell 2011 J. Med. Chem. 54 2529 10.1021/jm1013693 1:CAS:528:DC%2BC3MXjsVCnu7o%3D
- (2011) J. Med. Chem. , vol.54 , pp. 2529
- Meanwell, N.A.¹

7
- 0034067901
- Observations on the strength of hydrogen bonding
- DOI 10.1023/A:1008743229409
- C Laurence M Berthelot 2000 Perspect. Drug Discovery Des. 18 39 10.1023/A:1008743229409 1:CAS:528:DC%2BD3cXis12ju7g%3D (Pubitemid 30191022)
- (2000) Perspectives in Drug Discovery and Design , vol.18 , pp. 39-60
- Laurence, C.¹ Berthelot, M.²

8
- 37049068888
- M. H. Abraham, P. P. Duce, D. V. Prior, D. G. Barratt, J. J. Morris, P. J. Taylor, J. Chem. Soc., Perkin Trans. 2, 1355 (1989).
- (1989) J. Chem. Soc., Perkin Trans. , vol.2 , pp. 1355
- Abraham, M.H.¹ Duce, P.P.² Prior, D.V.³ Barratt, D.G.⁴ Morris, J.J.⁵ Taylor, P.J.⁶

9
- 34247108511
- M. H. Abraham, P. L. Grellier, D. V. Prior, P. P. Duce, J. J. Morris, P. J. Taylor, J. Chem. Soc., Perkin Trans. 2, 699 (1989).
- (1989) J. Chem. Soc., Perkin Trans. , vol.2 , pp. 699
- Abraham, M.H.¹ Grellier, P.L.² Prior, D.V.³ Duce, P.P.⁴ Morris, J.J.⁵ Taylor, P.J.⁶

10
- 67650763061
- 10.1021/jm801331y 1:CAS:528:DC%2BD1MXnsFKns7w%3D
- C Laurence KA Brameld J Graton J-Y Le Questel E Renault 2009 J. Med. Chem. 52 4073 10.1021/jm801331y 1:CAS:528:DC%2BD1MXnsFKns7w%3D
- (2009) J. Med. Chem. , vol.52 , pp. 4073
- Laurence, C.¹ Brameld, K.A.² Graton, J.³ Le Questel, J.-Y.⁴ Renault, E.⁵

11
- 0036893503
- Kinase inhibitors and the case for CH···O hydrogen bonds in protein-ligand binding
- DOI 10.1002/prot.10259
- AC Pierce KL Sandretto GW Bemis 2002 Proteins: Struct., Funct., Genet. 49 567 10.1002/prot.10259 1:CAS:528:DC%2BD38XptlGru7c%3D (Pubitemid 35390406)
- (2002) Proteins: Structure, Function and Genetics , vol.49 , Issue.4 , pp. 567-576
- Pierce, A.C.¹ Sandretto, K.L.² Bemis, G.W.³

12
- 72049110538
- 10.1016/j.bmcl.2009.10.054 1:CAS:528:DC%2BD1MXhtlGisLvE
- S Ioannidis ML Lamb AM Davies L Almeida M Su G Bebernitz M Ye K Bell M Alimzhanov M Zinda 2009 Bioorg. Med. Chem. Lett. 19 6524 10.1016/j.bmcl.2009.10. 054 1:CAS:528:DC%2BD1MXhtlGisLvE
- (2009) Bioorg. Med. Chem. Lett. , vol.19 , pp. 6524
- Ioannidis, S.¹ Lamb, M.L.² Davies, A.M.³ Almeida, L.⁴ Su, M.⁵ Bebernitz, G.⁶ Ye, M.⁷ Bell, K.⁸ Alimzhanov, M.⁹ Zinda, M.¹⁰

13
- 13944252481
- CHO and CHN hydrogen bonds in ligand design: A novel quinazolin-4- ylthiazol-2-ylamine protein kinase inhibitor
- DOI 10.1021/jm0492249
- AC Pierce E ter Haar HM Binch DP Kay SR Patel P Li 2005 J. Med. Chem. 48 1278 10.1021/jm0492249 1:CAS:528:DC%2BD2MXmsVensw%3D%3D (Pubitemid 40270474)
- (2005) Journal of Medicinal Chemistry , vol.48 , Issue.4 , pp. 1278-1281
- Pierce, A.C.¹ Ter Haar, E.² Binch, H.M.³ Kay, D.P.⁴ Patel, S.R.⁵ Li, P.⁶

14
- 77952721574
- 10.1021/jm1001452 1:CAS:528:DC%2BC3cXltVylsrc%3D
- ML Lolli C Giordano DS Pickering B Rolando KB Hansen A Foti A Contreras-Sanz A Amir R Fruttero A Gasco B Nielsen TN Johansen 2010 J. Med. Chem. 53 4110 10.1021/jm1001452 1:CAS:528:DC%2BC3cXltVylsrc%3D
- (2010) J. Med. Chem. , vol.53 , pp. 4110
- Lolli, M.L.¹ Giordano, C.² Pickering, D.S.³ Rolando, B.⁴ Hansen, K.B.⁵ Foti, A.⁶ Contreras-Sanz, A.⁷ Amir, A.⁸ Fruttero, R.⁹ Gasco, A.¹⁰ Nielsen, B.¹¹ Johansen, T.N.¹²

15
- 9744260986
- Potent N-(1,3-Thiazol-2-yl)pyridin-2-amine vascular endothelial growth factor receptor tyrosine kinase inhibitors with excellent pharmacokinetics and low affinity for the hERG ion channel
- DOI 10.1021/jm049697f
- MT Bilodeau AE Balitza TJ Koester PJ Manley LD Rodman C Buser-Doepner KE Coll C Fernandes JB Gibbs DC Heimbrook WR Huckle N Kohl JJ Lynch X Mao RC McFall D McLoughlin CM Miller-Stein KW Rickert L Sepp-Lorenzino JM Shipman R Subramanian KA Thomas BK Wong S Yu GD Hartman 2004 J. Med. Chem. 47 6363 10.1021/jm049697f 1:CAS:528:DC%2BD2cXptVaqsro%3D (Pubitemid 39587259)
- (2004) Journal of Medicinal Chemistry , vol.47 , Issue.25 , pp. 6363-6372
- Bilodeau, M.T.¹ Balitza, A.E.² Koester, T.J.³ Manley, P.J.⁴ Rodman, L.D.⁵ Buser-Doepner, C.⁶ Coll, K.E.⁷ Fernandes, C.⁸ Gibbs, J.B.⁹ Heimbrook, D.C.¹⁰ Huckle, W.R.¹¹ Kohl, N.¹² Lynch, J.J.¹³ Mao, X.¹⁴ McFall, R.C.¹⁵ McLoughlin, D.¹⁶ Miller-Stein, C.M.¹⁷ Rickert, K.W.¹⁸ Sepp-Lorenzino, L.¹⁹ Shipman, J.M.²⁰ more..

16
- 2342485125
- The discovery of N-(1,3-thiazol-2-yl)pyridin-2-amines as potent inhibitors of KDR kinase
- DOI 10.1016/j.bmcl.2004.03.052, PII S0960894X04003804
- MT Bilodeau LD Rodman GB McGaughey KE Coll TJ Koester WF Hoffman RW Hungate RL Kendall RC McFall KW Rickert RZ Rutledge KA Thomas 2004 Bioorg. Med. Chem. Lett. 14 2941 10.1016/j.bmcl.2004.03.052 1:CAS:528:DC%2BD2cXjs1amu78%3D (Pubitemid 38569768)
- (2004) Bioorganic and Medicinal Chemistry Letters , vol.14 , Issue.11 , pp. 2941-2945
- Bilodeau, M.T.¹ Rodman, L.D.² McGaughey, G.B.³ Coll, K.E.⁴ Koester, T.J.⁵ Hoffman, W.F.⁶ Hungate, R.W.⁷ Kendall, R.L.⁸ McFall, R.C.⁹ Rickert, K.W.¹⁰ Rutledge, R.Z.¹¹ Thomas, K.A.¹²

17
- 31344467295
- Potent 2-[(pyrimidin-4-yl)amine}-1,3-thiazole-5-carbonitrile-based inhibitors of VEGFR-2 (KDR) kinase
- DOI 10.1016/j.bmcl.2005.11.089, PII S0960894X05015179
- JT Sisko TJ Tucker MT Bilodeau CA Buser PA Ciecko KE Coll C Fernandes JB Gibbs TJ Koester N Kohl JJ Lynch X Mao D McLoughlin CM Miller-Stein LD Rodman KW Rickert L Sepp-Lorenzino JM Shipman KA Thomas BK Wong GD Hartman 2006 Bioorg. Med. Chem. Lett. 16 1146 10.1016/j.bmcl.2005.11.089 1:CAS:528: DC%2BD28Xoslyrsg%3D%3D (Pubitemid 43142980)
- (2006) Bioorganic and Medicinal Chemistry Letters , vol.16 , Issue.5 , pp. 1146-1150
- Sisko, J.T.¹ Tucker, T.J.² Bilodeau, M.T.³ Buser, C.A.⁴ Ciecko, P.A.⁵ Coll, K.E.⁶ Fernandes, C.⁷ Gibbs, J.B.⁸ Koester, T.J.⁹ Kohl, N.¹⁰ Lynch, J.J.¹¹ Mao, X.¹² McLoughlin, D.¹³ Miller-Stein, C.M.¹⁴ Rodman, L.D.¹⁵ Rickert, K.W.¹⁶ Sepp-Lorenzino, L.¹⁷ Shipman, J.M.¹⁸ Thomas, K.A.¹⁹ Wong, B.K.²⁰ Hartman, G.D.²¹ more..

18
- 76749117480
- 10.1016/j.bmcl.2010.01.091 1:CAS:528:DC%2BC3cXitlehsbY%3D
- S Ioannidis ML Lamb L Almeida H Guan B Peng G Bebernitz K Bell M Alimzhanov M Zinda 2010 Bioorg. Med. Chem. Lett. 20 1669 10.1016/j.bmcl.2010.01. 091 1:CAS:528:DC%2BC3cXitlehsbY%3D
- (2010) Bioorg. Med. Chem. Lett. , vol.20 , pp. 1669
- Ioannidis, S.¹ Lamb, M.L.² Almeida, L.³ Guan, H.⁴ Peng, B.⁵ Bebernitz, G.⁶ Bell, K.⁷ Alimzhanov, M.⁸ Zinda, M.⁹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.